Evidence mapPaperPMID 41367677Full record

ArticleERJ open research2025

French consensus statement on transition of adolescent and young adults with rare pulmonary disease from paediatric to adult care: a Delphi method study.

Elora Peulier-Maitre, Myrofora Goutaki, Nadia Nathan, Maxime Patout, Pascal Amedro, Guillaume Beltramo, Aurore Blonde, Damien Bonnet, Raphael Borie, Caroline Bruneaux and 30 more

Abstract read
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A Dialogic Participatory Model Between Professionals and Patients for the Co-Creation of Transitioning Care Management Programmes in Rare Bone Diseases.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Elora Peulier-MaitrePaediatric Pulmonology Department, Reference Center for Rare Lung Diseases RespiRare, Armand Trousseau Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France.
Myrofora GoutakiInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID https://orcid.org/0000-0001-8036-2092
Nadia NathanPaediatric Pulmonology Department, Reference Center for Rare Lung Diseases RespiRare, Armand Trousseau Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France.ORCID https://orcid.org/0000-0001-5149-7975
Maxime PatoutAP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, site Pitié-Salpêtrière, Service des Pathologies du Sommeil (Département R3S), Paris, France.ORCID https://orcid.org/0000-0002-1366-8726
Pascal AmedroDepartment of Fetal, Pediatric and Adult Congenital Cardiology, M3C National CHD Reference Centre, Bordeaux University Hospital, Haut-Leveque Hospital, Bordeaux, France.
Guillaume BeltramoConstitutive Reference Center for Rare Pulmonary Diseases, OrphaLung, Department of Pulmonary Medicine and Intensive Care Unit, Dijon-Bourgogne Universitary Hospital, Dijon, France.ORCID https://orcid.org/0000-0003-2830-5642
Aurore BlondeService de Médecine Infantile et CRCM Pédiatrique, Hôpital d'Enfants, CHRU de Nancy, Vandœuvre-les-Nancy, France.
Damien BonnetCentre de Référence Malformations Cardiaques Congénitales Complexes-M3C, Hôpital Universitaire Necker-Enfants Malades, APHP, Paris, France.
Raphael BorieUniversité de Paris, INSERM UMR 1152, Service de Pneumologie A, Centre de Compétences Maladies Pulmonaires Rares, Hôpital Bichat-Claude Bernard, AP-HP, Paris, France.ORCID https://orcid.org/0000-0002-9906-0024
Caroline BruneauxCentre de Ressources et de Compétence de la Mucoviscidose Pédiatrique, CHU Bordeaux, France.
Adele Carlier-GonodPediatrics Department, Centre Hospitalier Intercommunal de Créteil (CHIC), Créteil, France.
Virginie CoatrieuxCentre de Ressources et de Compétence de la Mucoviscidose Mixte, CHIC, Créteil, France.
Pierrick CrosDepartment of Pediatric, CHU Brest, Brest, France.
Benoit DouvryUniversité Paris Est-Créteil, Faculté de Santé, INSERM, IMRB, Créteil, France.
Jean-Christophe DubusService de Pneumologie Pédiatrique, CHU Timone enfants, Assistante Publique des Hôpitaux de Marseille, Marseille, France.
Nadine DufeuDepartment of Respiratory Medicine and Lung Transplantation, Aix Marseille Univ, APHM, Hôpital Nord, Marseille, France.
Yves DulacPediatric Cardiology, Hôpital des enfants, CHU de Toulouse, Toulouse, France.
Magali FerrySorbonne Université, Department of General practice, Paris, France.
Dominique GirardonAgastya, M.A.Form, Montlignon, France.
Suzy GonsseaumeCentre de Ressources et de Compétences de la Mucoviscidose Pédiatrique, CHU Robert Debré, Paris, France.
Anne-Cecile GrangeFilière de Santé Nationale Maladies Rares CARDIOGEN, Bordeaux, France.
Frederic HameuryDepartment of Pediatric Surgery, Hôpital Femme Mère-Enfant, Hospices Civils de Lyon, Bron, France.
Sandrine JaffreNantes Université, CHU Nantes, Department of Respiratory Medicine, l'Institut du Thorax, Nantes, France.
Magalie LadouceurDepartment of Cardiology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
Catherine LlerenaCentre de Ressources et de Compétences de la Mucoviscidose, Département de Pédiatrie, CHU de Grenoble, Grenoble, France.
Farida MadaouiEspace de Soins et de Coordination de l'Adolescent et de son Entourage ESCALE, Hôpital Armand Trousseau, APHP, Paris, France.
Effrosyni ManaliPulmonary Medicine Department, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Helene MellerioUniversité de Paris, ECEVE UMR 1123, Inserm, Paris, France.
Marie MittaineCRCM Pédiatrique, Service de Pneumo-Allergologie Pédiatrique, Hôpital des Enfants, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
Maxime MorsaAdaptation, Resilience and Change Research Unit, University of Liège, Liège, Belgium.
Jean-Francois PaponAPHP, Université Paris-Saclay, Hôpital Bicêtre, Service d'ORL, Le Kremlin-Bicêtre, France.
Elsa SchwartzPediatric Neurology Department, Reference Centre for Neuromuscular Diseases, Armand Trousseau Hospital, APHP, Paris, France.
Olivier SitbonFaculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0002-1942-1951
Isabelle SzezepanskiCentre de Référence Malformations Cardiaques Congénitales Complexes-M3C, Hôpital Universitaire Necker-Enfants Malades, APHP, Paris, France.
Manon TessierService des Maladies Héréditaires du Métabolisme, Hôpital Necker Enfants Malades, APHP, Paris, France.
Marie-Christine Werck-GalloisService de Pneumologie, Allergologie, Mucoviscidose, Centre de Compétences Pour Les Maladies Respiratoires Rares de L'enfant, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon, France.
Melisa ZemouriPaediatric Pulmonology Department, Reference Center for Rare Lung Diseases RespiRare, Armand Trousseau Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France.
Sebastien HascoetPeadiatric and Congenital Cardiac Surgery Department, Marie-Lannelongue Hospital, Centre de Référence des Malformations Cardiaques Congénitales Complexes M3C Groupe Hospitalier Saint-Joseph, Paris-Saclay University, Le Plessis Robinson, France.
Natascha RemusCentre de Ressources et de Compétence de la Mucoviscidose Mixte, CHIC, Créteil, France.
Guillaume ThouveninPaediatric Pulmonology Department, Reference Center for Rare Lung Diseases RespiRare, Armand Trousseau Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France.ORCID https://orcid.org/0000-0003-0528-5458

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Transition of adolescents with chronic diseases to adult care is at risk of health complications and loss of medical follow-up. There is currently no official general consensus specific to rare pulmonary diseases. We aimed at setting up a consensus of experts to establish a consensus statement for the transition of patients with rare pulmonary diseases in France. Methods: We sought consensus using a three-round Delphi method, involving the French rare lung disease network. Statements were submitted to a panel of 38 experts (including nurses, patients, physiotherapists, specialised and general physicians, social workers and psychologists). A statement was validated if 80% of the respondents rated it as 7 or more on a Likert scale. Results: We received all three completed surveys from 37 respondents. We identified 77 key elements that reached consensus to be included in future guidelines. The main topics discussed correspond to the future guidelines' structure, as follows: Transition overview and main objectives; Subjects to discuss with the patient during transition; Practical aspects of consultations during transition and transfer; and early follow-up in adult care. The main remaining ideas were: 1) to coordinate global care for each patient; 2) to formalise transfer; and 3) to integrate patients' will and needs into their care in order to support their empowerment. Conclusion: This study has established key elements to a successful transition for patients with rare pulmonary disease by a multidisciplinary panel of experts. We achieved consensus on a formalised transition pathway to guarantee a successful transition for patients and their families, and also for healthcare professionals.

Identifiers

PMID41367677
PMCPMC12683595

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.